Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
30
2015
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
Nov
30
2022
HHS Proposes to Align Federal Substance Use Disorder Law with HIPAA Foley & Lardner LLP
Jul
21
2015
DNA Sequencing Patents: Simultaneous Invention As Secondary Evidence Of Obviousness Foley & Lardner LLP
Aug
28
2015
FDA’s Proposed Naming Convention for Biologics Foley & Lardner LLP
Sep
8
2015
Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits Foley & Lardner LLP
Oct
8
2015
Australia High Court Rules Against Gene Patents Foley & Lardner LLP
Nov
16
2015
Federal Circuit To Revisit On Sale Bar Triggered By Contract Manufacture Foley & Lardner LLP
Nov
11
2019
Telehealth: Medicare Finalizes New Services for 2020 in Physician Fee Schedule Foley & Lardner LLP
Dec
15
2015
Biosimilar Pre-Marketing Notice Always Required Foley & Lardner LLP
May
16
2023
Supreme Court Won’t Hear Skinny Label Case Foley & Lardner LLP
Mar
17
2020
Managing the Commercial Impact of the Coronavirus: FAQs for the Life Sciences Industry Foley & Lardner LLP
May
12
2016
New USPTO Guidance On Patent Eligibility Of Natural Products Foley & Lardner LLP
Mar
31
2020
Utilization of Natural Phenomenon Found Patent Eligible Foley & Lardner LLP
Jun
27
2016
Supreme Court Declines to Review Sequenom Ruling Foley & Lardner LLP
Mar
12
2024
Cancer Drugs: Antibody Drug Conjugates (ADCs) Keep Growing Foley & Lardner LLP
Apr
18
2017
Angiomax Patents Limited To Example Foley & Lardner LLP
May
15
2024
Keeping Track of Your Data — What You Need to Know about FDA’s Draft Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies Foley & Lardner LLP
Jul
31
2017
Massachusetts Court Clouds Marijuana in the Workplace Issues Foley & Lardner LLP
Sep
7
2017
FDA Marketing Exclusivity Periods Limited To Same Active Moiety Foley & Lardner LLP
May
29
2018
“High” Stakes for Employers Dealing With Evolving Cannabis Laws Foley & Lardner LLP
Aug
30
2021
Seventh Circuit Endorses Objective Reasonableness as a Defense under the FCA Foley & Lardner LLP
Dec
21
2021
New Prescription Drug and Health Care Spending Reporting Requirements from a Carrier and Plan Service Provider Perspective Foley & Lardner LLP
Jan
14
2019
Michigan Brings Legalized Recreational Marijuana to the Midwest Foley & Lardner LLP
Feb
15
2022
Episode 19: Health Care Industry Trends and Lessons Learned from the Commonwealth [PODCAST] Foley & Lardner LLP
Apr
2
2019
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Jun
7
2022
June 2022 Food and Beverage Review: Litigation Foley & Lardner LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Nov
15
2022
USPTO Continues Discussion of Pharmaceutical Patents Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins